| CDK2 |
CDK2: Cell division protein kinase 2 |
ARFGAP1 |
IPI00175169 |
14.100 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
EIF5AP1 |
EIF5A: Eukaryotic translation initiation factor 5A-1 |
14.100 |
Evidence |
|
| GFAP |
GFAP: Glial fibrillary acidic protein |
VSNL1 |
VSNL1, VISL1: Visinin-like protein 1 |
14.100 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
PLA2G7 |
PAFAH, PLA2G7: Platelet-activating factor acetylhydrolase precursor |
14.100 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
14.100 |
Evidence |
|
| APOM |
APOM, G3A, HSPC336, NG20: Apolipoprotein M |
C1R |
C1R: Complement C1r subcomponent precursor |
14.100 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
14.100 |
Evidence |
|
| ITGB1BP1 |
ITGB1BP1, ICAP1: Integrin beta-1-binding protein 1 |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
14.100 |
Evidence |
|
| RAP1A |
RAP1A, KREV1: Ras-related protein Rap-1A precursor |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
14.070 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
14.070 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
14.070 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
14.070 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
14.070 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
14.070 |
Evidence |
|
| RPL3 |
RPL3, OK/SW-cl.32: 60S ribosomal protein L3 |
C20orf6 |
ESF1, ABTAP, HDCMC28P, C20orf6: ESF1 homolog |
14.030 |
Evidence |
|
| SKI |
SKI: Ski oncogene |
PLCD1 |
DKFZp686K101: Putative uncharacterized protein DKFZp686K101 |
14.010 |
Evidence |
|
| GADD45G |
GADD45G, CR6, DDIT2: Growth arrest and DNA-damage-inducible protein GADD45 gamma |
HIST1H2BG |
HIST1H2BC, H2BFL, HIST1H2BE, H2BFH, HIST1H2BF, H2BFG, HIST1H2BG, H2BFA, HIST1H2B |
14.010 |
Evidence |
|
| PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
PCBP1 |
PCBP1: Poly(rC)-binding protein 1 |
14.000 |
Evidence |
|
| MYH9 |
MYH9: Myosin-9 |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
14.000 |
Evidence |
|
| UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
13.960 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
13.950 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
13.950 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
13.950 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
13.930 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
13.930 |
Evidence |
|
- 
-